Major non-cardiac surgery is associated with significant postoperative morbidity. The risk of postoperative complications increases, as does hospital length-of-stay, in the presence of patient factors such as age, cardiovascular and respiratory fitness, surgical complexity and duration of surgery 1-3 . Postoperative complications may also affect long-term survival 4 . If it were possible to accurately identify patients at high risk of perioperative morbidity and mortality, they could be selected for additional intraoperative and postoperative haemodynamic monitoring and targeted intervention. This clinical approach has been called 'goal-directed therapy' 5 .
RElATIoNSHIP oF INTRAoPERATIvE SCvo 2 To oUTCoMES
Anaesthesia and Intensive Care, Vol. 42, No. 1, January 2014 Perioperative central venous oxygen saturation (Scvo 2 ) has been shown to be a predictor of operative morbidity with optimal cut-off values of 64.4% and 73.0% in high-risk surgical patients 20, 21 , whilst in a single centre study, a protocol which included a target Scvo 2 >70% resulted in improved mortality in patients with septic shock 22 . The bundle of therapies and endpoints used in the study by Rivers et al 22 has been termed 'early goal-directed therapy' and has been included in the international guidelines for the management of severe sepsis and septic shock 23 . In the setting of paediatric cardiac surgery, prolonged postoperative Scvo 2 desaturation has been associated with major adverse events 24 .
To date, there has been little work specifically designed to test the hypothesis that the Scvo 2 is important during high-risk adult non-cardiac surgery. The measurement of Scvo 2 is an attractive option in developing therapeutic targets during high-risk surgery because the use of a central venous line (Cvl) is routine in the intraoperative management of these patients and the technology is available to continuously measure Scvo 2 by reflection spectrophotometry during the procedure.
We have conducted a pilot study in order to define the range and time course of Scvo 2 values during the operative period in an attempt to identify associations between Scvo 2 and patients experiencing postoperative complications. Secondarily, we hoped to identify any potential targets for a goal-directed approach during the operative period.
MATERIAl AND METHoDS
After institutional ethical approval (Approval number: 09/022), we conducted a prospective, noninterventional observational study. We planned to enrol a convenience sample of 60 adult patients undergoing high-risk abdominal or retroperitoneal surgery requiring placement of a central venous catheter into the superior vena cava for anaesthetic and postoperative management. All enrolled patients gave informed consent to participate in this study.
Inclusion and exclusion criteria
Criteria for 'high risk' were an expected duration of surgery greater than 90 minutes and one or more of the following: cardiac or respiratory illness resulting in significant functional limitation defined as American Society of Anesthesiologists (ASA) Class III or greater, extensive surgery planned for carcinoma involving bowel anastomoses, predicted massive blood loss (>2.5 litres), age over 70 years with moderate functional limitation of one or more organ systems (including end-stage kidney disease), sepsis (positive blood cultures or septic focus), respiratory failure (Pao 2 <60 mmHg on Fio 2 >0.4, i.e. Pao 2 :Fio 2 ratio <150, or mechanical ventilation >48 hours, acute abdominal catastrophe (e.g. pancreatitis, perforated viscus, gastrointestinal bleed with haemodynamic disturbance, acute renal failure (urea >20 mmol/l, creatinine >0.26 mmol/l) or surgery for abdominal aortic aneurysm. These reflect the criteria initially proposed by Shoemaker and adapted by Boyd 25 .
Patients were excluded if any of the following applied: primary hepatic or hepatobiliary surgery, acute myocardial ischaemia (defined by a raised troponin prior to enrolment), patients receiving palliative treatment only or the presence of disseminated malignancy.
Patient management and data collection
A fibreoptic 3-lumen oximetric Cvl (PreSep, Edwards lifesciences Pty ltd, Sydney, Australia) was substituted for the standard Cvl and management was undertaken according to the usual anaesthetic practice. Specifically, the Cvl could be inserted before or after induction, according to the procedural anaesthetist's preference. one of the authors assisted in the establishment of Scvo 2 monitoring. Prior to insertion, the oximetric catheter was connected to a patient monitor (vigileo, Edwards lifesciences Pty ltd, Sydney, Australia) and calibrated in vitro, using the most recent haemoglobin value. The haemoglobin values entered in the device were updated in the event of significant blood loss or whenever a measurement was taken. once the catheter was inserted, the procedural anaesthetist was kept unaware of the Scvo 2 readings for the duration of the case.
Digital data was captured at two second intervals and stored on computer using vigileo Multi-Data logger v1/6.05 software (Edwards lifesciences Pty ltd, Sydney, Australia) and stored for later analysis. The haemoglobin value used by the oximetric monitor was updated as values became available during the intraoperative period.
The anaesthetic record, operation report and patient notes were reviewed postoperatively and the following data recorded: Physiological and operative Severity Score for the enumeration of Mortality and Morbidity (PoSSUM) 26, 27 , ASA score, duration of surgery (start to end surgery as per the procedure documentation), estimated intraoperative blood loss, any use of vasoactive and inotropic medications, the volume of intravenous fluid (crystalloid, colloid, blood) administered intraoperatively, intensive care unit length-of-stay, hospital length-of-stay (censored at 28 days) and 28-day mortality. Any missing data was sought from the procedural anaesthetist.
Postoperative complications were prospectively defined (see Appendix) and determined by a review of the medical record by one of the authors (not involved in Scvo 2 data recording and data entry).
Data processing
Correct Cvl position was established by reviewing the postoperative chest X-ray. Digitalised Scvo 2 data was culled using the signal quality indicator (SQI) (order of preference SQI 1 to SQI 3) so that there was one data point per minute using the recorded time stamp. Data points with SQI 4 were accepted if of short duration (up to five minutes) and the Scvo 2 values were consistent with pre and post Scvo 2 values with SQI 1 to 3. Missing values were interpolated by averaging Scvo 2 values for the previous and following five minutes.
Analysis
Continuous data are displayed as mean ± standard deviation or median and interquartile range for normally distributed and non-normally distributed data respectively. Normality was assessed using the Kolmogorov-Smirnov test. Differences for continuous data were tested using parametric and nonparametric statistics as appropriate. Categorical data are presented as count and percent and differ-ences tested using a chi-squared test statistic. Correlations between variables were determined using Fisher's r to z statistic or Spearman rank correlation.
An estimation of oxygen extraction ratio (o 2 ER est ) was calculated using (Spo 2 -Scvo 2 )/Spo 2 ×100 every ten minutes during the surgical period by averaging ten minutes of Scvo 2 and Spo 2 values around the time stamp. o 2 ER est was also determined for the start and end of surgery by averaging ten minutes of Scvo 2 values around ten minutes after surgery commenced and ten minutes before surgery ended. The change in o 2 ER est for the two times was calculated as; o 2 ER end -o 2 ER start .
The area under the curve for Scvo 2 with respect to time for different cut-off values was calculated as cut-off value -actual value, where zero and negative values were assigned zero time and a positive value equalled the Scvo 2 value less than the cut-off. The area under the curve equalled the sum of the Scvo 2 values less than the cut-off (%.minutes) 24 .
Receiver operator characteristic curves were drawn to determine the optimal cut-off value (greatest sum of specificity and sensitivity) for association with outcome (complications).
A multiple logistic regression model was used to identify independent risk factors for 
RESUlTS
The study was conducted from May 2010 until october 2012 at a metropolitan teaching hospital. During this period 78 patients met the inclusion criteria. of these, four declined consent, a Cvl other than a 3-lumen line was to be used in another four patients and 15 were missed because of unavailability of study personnel. Sixty-three patients were enrolled but of these 12 were excluded from analysis (Cvl not in superior vena cava=5, did not meet inclusion criteria=1, equipment-related=6), leaving 51 patients in the analysis.
Thirty-one (61%) of the 51 patients included were male and the mean age of the group was 66±14 years (range 24 to 89 years). Patient demographics, ASA status, operation category, surgery duration, blood loss and intravenous fluid infusion volumes are presented in Table 1 . Although postoperative admission to the intensive care had been planned, ten (20%) of the patients were returned to a surgical ward subsequent to postoperative assessment and after a period of recovery in a post-anaesthesia care unit.
Complications
Two (4%) participants died in hospital and 24 (47%) had at least one postoperative complication (range 1 to 5). There were 35 postoperative complications (i.e. 69 per 100 patients) with infections (37%) and abdominal complications (31%) predominant. The PoSSUM predicted death rate and PoSSUM predicted morbidity rate were 12% and 57% respectively. The mean hospital length-of-stay (censored at 28 days) was 15.5±8.0 days and was longer in those with at least one complication compared to those without (22.1±6.1 and 9.6±3.6 days respectively, P <0.0001) ( Table 2 ). The mean surgery duration was also longer in those with one or more complications compared to those without (328±162 minutes versus 241±94 minutes, P=0.02) ( Table 1) .
Central venous saturation
The total intraoperative period observed for the 51 patients was 14,271 minutes. The distribution of all Scvo 2 values over that time is presented in Figure 1 . overall, the mean Scvo 2 for the pooled observations was 82±8% and ranged from 40% to 97%. Seventeen patients (33%) experienced at least one episode of Scvo 2 <70%. However, only seven (14%) experienced a cumulative time of >10 minutes with Scvo 2 <70% and, of these, five (71%) experienced at least one postoperative complication (chi-squared test 1.9, P=0.16). The mean Scvo 2 for those with and without a postoperative complication were 81±9% and 82±6% respectively (P <0.0001).
The total time the Scvo 2 was <90% was significantly greater in those with a complication compared to those without (300±152 minutes versus 213±81 minutes (P=0.01). There were no significant differences for those with or without a complication for the average and lowest Scvo 2 , or the Scvo 2 at either the start or finish of surgery. Similarly, there were no differences in the rate of complications when analysing the area under the curve for the time spent with less than the cut-off values of 90%, 85% or 80%. The area under the curve and time for the Scvo 2 cut-offs were highly correlated to the duration of surgery (Table 3) .
Oxygen extraction ratio
The o 2 ER est for pooled data split by with complication/without complication were 17.4±8.8% versus 16.3±6.9% (P=0.009). However, there were no differences between those with and without complications in the o 2 ER est at the start and finish of surgery, or for the change from start to finish for individual patients (Table 3) .
Correlations with the number of postoperative complications
Four variables were correlated with the number of postoperative complications: hospital length-ofstay (rho 0.8, P <0.0001), time Scvo 2 <90% (rho 0.4, P=0.003), surgery duration (rho 0.4, P=0.005) and blood loss (rho 0.32, P=0.02).
Receiver operator characteristic curve analysis for the occurrence of a complication using both proportion of time spent with Scvo 2 saturation <90% and duration of surgery did not suggest any statistically significant predictive power for either variable (59%, [95% confidence interval, 44 to 75%]; P=0.025; and 67%, [95% confidence interval 50 to 82%]; P=0.06) ( Figure 2 ).
Regression model
A logistic model which included ASA classification, surgery duration and change in o 2 ER est from the value at the start to the value at the finish of surgery had a significant whole model fit likelihood ratio (DF 5, chi-square 15.7, P=0.008). The adjusted odds ratio for surgery duration was 1.008 (95% confidence interval 1.002 to 1.013, P=0.006) and for change in o 2 ER est was 1.13 (95% confidence interval 1.001 to 1.28, P=0.04). The model has classification positive and negative predictive values of 75% and 74% respectively and R 2 0.22.
DISCUSSIoN
our observational study of 51 high-risk general surgical patients revealed a postoperative complication rate of 47% and mortality at 28 days of 3.9%. The average Scvo 2 during surgery was 82% and only 7% of Scvo 2 (minute intervals) values were less than 70% with 33% of patients experiencing at least one Scvo 2 measurement of <70%. Those patients suffering at least one complication had longer duration of surgery and hospital length-of-stay. The number of postoperative complications increased with increasing blood loss and duration of surgery. overall the Scvo 2 was lower and the o 2 ER est higher in those having a complication, although these differences were small. The derived Scvo 2 parameters of Scvo 2 time and Scvo 2 area under the curve for <90% were significantly greater for those with complications; however, these parameters were highly correlated with the duration of surgery. Multivariate analysis supported the importance of both the duration of surgery and an increased o 2 ER est at the end of surgery as factors related to the development of complications. The final logistic model suggests that each ten-minute increase in surgical duration increased the odds of complication by 8% and by 13% for a unit increase in o 2 ER est over the course of surgery.
It has been suggested that the mixed venous oxygen saturation (Svo 2 ) and central venous Scvo 2 reflect the balance between oxygen delivery and tissue oxygen utilisation 28 . The accepted normal values of Svo 2 are from 65% to 75% and of Scvo 2 from 70% to 80%. They are therefore not interchangeable. venous oxygen saturations vary depending upon the site of measurement because different organ systems extract different amounts of oxygen under normal and pathophysiological conditions (varying, for example, with abdominal sepsis, general anaesthesia, head trauma and shunting at the microvascular level). Scvo 2 mainly reflects the relationship of oxygen supply and demand from the upper body. It has also been demonstrated to track changes in Svo 2 in some studies 29, 30 . Both Svo 2 and Scvo 2 fall when compensatory mechanisms fail to maintain oxygen delivery commensurate with demand 28 . A falling Scvo 2 is thus an indication of increasing tissue 'stress'. The Scvo 2 reflects the patient's physiological response to surgical stress and such a measure may help to 'individualise' goal-directed or targeted therapy. This is of great importance because inappropriately applied goal-directed therapy may produce adverse outcomes 31 . The role and importance of microvascular derangements in the genesis of postoperative complications must also be considered as microvascular function is not necessarily influenced by targeting macrocirculatory parameters [32] [33] [34] .
A recent study in paediatric cardiac surgery demonstrated that prolonged desaturation (>18 minutes with Scvo 2 <40%) was associated with major adverse events 24 . In contrast to our study, these observations were made in the post-surgical period. our study demonstrated that overall, patients maintained a relatively high Scvo 2 under anaesthesia during the surgical period. We did not undertake to correlate periods of desaturation with events such as haemorrhage, dysrhythmia and hypotension, although these were observed on occasion. The observation that an increase in physiological stress, as measured by the o 2 extraction ratio increase over the course of surgery, was independently associated with complications, is consistent with the notion that outcomes may be related to the individual's physiological reserve. Increasing surgical duration may also reflect the magnitude of physiological stress imposed, which is supported by the observation of the correlation of surgical duration with blood loss. A relationship has been demonstrated between low perioperative haemoglobin and increased morbidity 21 .
The optimal mean Scvo 2 to discriminate between patients who did or did not develop complications was 73% (sensitivity 72%, specificity 61%). Interestingly, those with complications had lower preoperative and intraoperative Scvo 2 (71±11% versus 81±8% after three hours of surgery) compared to those without complications 21 . In contrast to our study, 20% of patients underwent emergency surgery and 47% underwent major aortic surgery 21 . overall mortality was 10%, while 53% had complications. Although blood loss and use of blood transfusion was not reported, it is possible that these patients experienced greater stress during the surgical period which accounts for the significant difference in the surgical period Scvo 2 and the impact on morbidity and mortality. Further studies are needed to confirm or refute the importance of blood loss and blood administration as independent predictors of postoperative complications. This is a small observational study in a single centre and therefore we were unable to control for potential bias resulting from factors such as differences in surgical and anaesthetic practice. our regression model had an R 2 of only 0.22 and therefore only explains a small fraction of the observed complications. Also the small sample size limited the identification of factors occurring during surgery that may contribute to the development of postoperative complications. We were unable to demonstrate a threshold value of Scvo 2 or time-weighted Scvo 2 (area under the curve) that could be used as part of a targeted intraoperative haemodynamic intervention strategy, the major factor influencing the development of postoperative complications being the duration of surgery. of course, postoperative management may also influence patient outcome. The rate of patient complication and mortality we observed in patients receiving routine intraoperative and postoperative care are similar to the results reported for the intervention group in a recent trial of goal-directed therapy in the postoperative period. The patients in this survey were similar in terms of age, gender and type of surgery and were also similar in terms of surgical risk, as determined by the PoSSUM scores 8 .
A relationship between perioperative Scvo 2 and postoperative morbidity has been described in previous studies using intermittent Scvo 2 measurements 11, 20, 21 . These studies have not been controlled for the duration of surgery, a factor we found to be significant. This is the first report, to our knowledge, of continuous intraoperative Scvo 2 monitoring in this patient group. The relatively high Scvo 2 we observed during the surgical period is consistent with the reduced oxygen demand under anaesthesia and the use of higher Fio 2 for ventilation and suggests that an intervention strategy should focus on maintaining oxygen delivery by attention to arterial oxygen saturation, haemoglobin concentration and cardiac output.
In conclusion, in this observational study we have demonstrated an association between postoperative complications and duration of surgery, increased oxygen extraction at the end of surgery compared to the beginning, and increasing ASA classification in a multivariate regression model.
While the Scvo 2 is lower on average and lower for a longer period of time in those who will have a complication, the differences are modest, there are no clear cut-off values to guide clinical practice and we could not generate a useful prediction model for postoperative complications using the data available at the start of an individual case.
In general, anaesthetists administer a relatively high Fio 2 during surgery, and this may blunt the response of Scvo 2 to deleterious events during the operative period. While this study was not designed to identify specific temporal relationships between adverse events and changes in Scvo 2 , it nevertheless remains possible that continuous Scvo 2 monitoring is of value to provide an 'early warning' of adverse cardiovascular/respiratory events in individual patients and that this strategy deserves more study. We recommend that future investigations in this area also seek to define any relationship between intraoperative events, Scvo 2 and red cell transfusionpreferably in a more homogeneous group in order to reduce the potential for confounding.
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